| scholarly article | Q13442814 |
| P2093 | author name string | S Walker | |
| P Roderick | |||
| N Drey | |||
| J Stevens | |||
| N Hedger | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pauci-immune | Q7148839 |
| glomerulonephritis | Q605006 | ||
| rapidly progressive glomerulonephritis | Q1509367 | ||
| P304 | page(s) | 1593-9 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study | |
| P478 | volume | 15 |
| Q38601673 | A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis |
| Q33884806 | ANCA negative pauci-immune glomerulonephritis with systemic involvement |
| Q35901670 | ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis Linked with Non-Small Cell Carcinoma of the Lung |
| Q37462164 | ANCA-negative pauci-immune crescentic glomerulonephritis |
| Q46458557 | ANCA-negative pauci-immune renal vasculitis: histology and outcome |
| Q27023640 | Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody |
| Q54560537 | Antineutrophil cytoplasmic antibody (ANCA) testing: Audit from a clinical immunology laboratory. |
| Q41361340 | Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis |
| Q40522760 | Antineutrophil cytoplasmic antibody-associated glomerulonephritis in Taiwanese |
| Q54241537 | Assessment of the etiologies and renal outcomes of rapidly progressive glomerulonephritis in pediatric patients at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. |
| Q37604720 | Autoantibodies to hLAMP-2 in ANCA-negative pauci-immune focal necrotizing GN |
| Q40373160 | CD4+CD28null T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis |
| Q33862188 | Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans |
| Q39501307 | Clinical spectrum and outcomes of crescentic glomerulonephritis: A single center experience. |
| Q48227464 | Clinical, serological and histological determinants of patient and renal outcome in ANCA-associated vasculitis with renal involvement: an analysis from a referral centre. |
| Q90705609 | Clinicopathological features and prognostic analysis of 49 cases with crescentic glomerulonephritis |
| Q53361163 | Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis. |
| Q42421542 | Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study |
| Q57825808 | Histopathological Classification-A Prognostic Tool for Rapidly Progressive Glomerulonephritis |
| Q80230637 | Hypoxia pathway linked to kidney failure |
| Q45034297 | Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study. |
| Q50598390 | Incidence and disease severity of anti-neutrophil cytoplasmic antibody-associated nephritis are higher than in lupus nephritis in Sweden. |
| Q64043729 | Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort |
| Q64268196 | Individualised Homeopathic Therapy in ANCA Negative Rapidly Progressive Necrotising Crescentic Glomerulonephritis with Severe Renal Insufficiency - A Case Report |
| Q36735825 | Long-term Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Negative Renal Vasculitis: Cohort Study in Korea |
| Q80102490 | Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice |
| Q42207264 | Medullary angiitis and pauci-immune crescentic glomerulonephritis. |
| Q47547320 | Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis developed from ANCA negative renal limited vasculitis: A case report |
| Q39309487 | Pauci-immune crescentic glomerulonephritis associated with use of trimethoprim-sulfamethoxazole |
| Q45917648 | Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters? |
| Q79136036 | Poor renal outcome of antineutrophil cytoplasmic antibody negative Pauci-immune glomerulonephritis in Taiwanese |
| Q33571802 | Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure |
| Q55414747 | Pulmonary renal syndrome: A case report of diffuse alveolar hemorrhage in association with ANCA negative pauci-immune glomerulonephritis. |
| Q40846273 | Recurrence of ANCA-negative renal-limited pauci-immune glomerulonephritis in the renal allograft |
| Q36662060 | Renal biopsy findings in acute renal failure in the cohort of patients in the Spanish Registry of Glomerulonephritis |
| Q37300789 | Renal biopsy registry from a single centre in Serbia: 20 years of experience |
| Q40295571 | Renal vasculitis presenting with acute kidney injury |
| Q35587408 | The effect of a symptom related "gating policy" on ANCA requests in routine clinical practice |
| Q38512570 | The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis |
| Q37421814 | Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis |
| Q91748961 | Trends of renal diseases in Germany: review of a regional renal biopsy database from 1990 to 2013 |
| Q35151217 | Urinary thrombin: a novel marker of glomerular inflammation for the diagnosis of crescentic glomerulonephritis (prospective observational study) |
| Q43012646 | Vasculitis masquerading as aortic valve endocarditis |
Search more.